BioStock: CombiGene’s CEO comments on the patent approvals in Australia and India
CombiGene was granted patents in Australia and India for the CG01 epilepsy project, and the objection period recently passed. BioStock spoke with CEO Peter Ekolind, who believes that this strengthens the project and increases the value ahead of a potential partnership.
Read the full interview with Peter Ekolind at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/